Your browser doesn't support javascript.
loading
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins.
Matthews, Alicia M; Biel, Thomas G; Ortega-Rodriguez, Uriel; Falkowski, Vincent M; Bush, Xin; Faison, Talia; Xie, Hang; Agarabi, Cyrus; Rao, V Ashutosh; Ju, Tongzhong.
Affiliation
  • Matthews AM; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Biel TG; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Ortega-Rodriguez U; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Falkowski VM; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Bush X; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, United States of America.
  • Faison T; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Xie H; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Agarabi C; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Rao VA; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Ju T; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
PLoS One ; 17(12): e0278294, 2022.
Article in En | MEDLINE | ID: mdl-36472974

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos